CRSP Competitors & Alternatives
Compare Crispr Therapeutics AG with similar stocks in the same industry
Biotechnology
CRSP
Main Stock$55.43
Tradestie Score
54
Market Cap
$6.02B
Revenue Growth
10.4%
Analyst Upside
+58.0%
Top Competitors
229 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ABVX
Abivax SA American Depositary Shares
|
$92.88
|
$6.38B | - | 67 | Compare |
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$18.57
|
$6.03B | - | 46 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.96
|
$5.95B | - | 44 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$179.25
|
$5.92B | - | 42 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$54.29
|
$5.80B | 20.4 | 34 | Compare |
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$322.28
|
$5.20B | 40.8 | 63 | Compare |
|
PCVX
Vaxcyte, Inc. Common Stock
|
$56.48
|
$4.94B | - | 57 | Compare |
|
PTCT
PTC Therapeutics, Inc.
|
$63.46
|
$4.93B | - | 54 | Compare |
|
ARWR
Arrowhead Research Corporation
|
$64.19
|
$4.84B | - | 67 | Compare |
|
ACLX
Arcellx, Inc. Common Stock
|
$115.07
|
$4.55B | - | 50 | Compare |
More CRSP Analysis
Data updated: Oct 03, 2026 | Industry: Biotechnology (SIC 2836)
229 stocks in this industry